Hepion Pharmaceuticals, Inc. (HEPA)
0.066
-0.01
(-7.11%)
USD |
OTCM |
Sep 03, 16:00
Hepion Pharmaceuticals Enterprise Value : 1.988M for Sept. 3, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 1.988M |
| September 02, 2026 | 2.136M |
| September 01, 2026 | 2.250M |
| August 31, 2026 | 2.382M |
| August 28, 2026 | 2.833M |
| August 27, 2026 | 1.610M |
| August 26, 2026 | 1.959M |
| August 25, 2026 | 2.221M |
| August 24, 2026 | 1.843M |
| August 21, 2026 | 2.250M |
| August 20, 2026 | 2.250M |
| August 19, 2026 | 2.250M |
| August 18, 2026 | 2.250M |
| August 17, 2026 | 2.250M |
| August 14, 2026 | 2.250M |
| August 13, 2026 | 2.105M |
| August 12, 2026 | 1.552M |
| August 11, 2026 | 1.552M |
| August 10, 2026 | 1.814M |
| August 07, 2026 | 1.467M |
| August 06, 2026 | 1.814M |
| August 05, 2026 | 2.102M |
| August 04, 2026 | 1.77M |
| August 03, 2026 | 2.152M |
| July 31, 2026 | 1.403M |
| Date | Value |
|---|---|
| July 30, 2026 | 1.406M |
| July 29, 2026 | 1.756M |
| July 28, 2026 | 1.770M |
| July 27, 2026 | 1.965M |
| July 24, 2026 | 1.624M |
| July 23, 2026 | 1.392M |
| July 22, 2026 | 1.624M |
| July 21, 2026 | 1.624M |
| July 20, 2026 | 1.377M |
| July 17, 2026 | 1.843M |
| July 16, 2026 | 1.683M |
| July 15, 2026 | 1.668M |
| July 14, 2026 | 1.814M |
| July 13, 2026 | 1.814M |
| July 10, 2026 | 1.814M |
| July 09, 2026 | 2.105M |
| July 08, 2026 | 1.963M |
| July 07, 2026 | 2.367M |
| July 06, 2026 | 2.367M |
| July 02, 2026 | 2.504M |
| July 01, 2026 | 1.814M |
| June 30, 2026 | 2.042M |
| June 29, 2026 | -0.1173M |
| June 26, 2026 | -0.28M |
| June 25, 2026 | -0.312M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.888B |
| Corcept Therapeutics, Inc. | 11.87B |
| Veru, Inc. | 22.07M |
| Johnson & Johnson | 698.80B |
| Eli Lilly & Co. | 1.138T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.248M |
| Total Expenses (Quarterly) | 1.248M |
| EPS Diluted (Quarterly) | -0.0771 |
| Earnings Yield | -369.8% |
| Normalized Earnings Yield | -367.12 |